AstraZeneca Pharma India Ltd

NSE: ASTRAZEN · BSE: 506820 · Pharmaceuticals & Biotechnology · 42 announcements

Share price: ₹5,848.50
Market cap: ₹14,621 Cr
Revenue (annual): ₹2,276 Cr
Net profit (annual): ₹187.5 Cr
P/E (TTM): 86.2×Sector 47.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 2.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 8 Regulatory Approval 6 Legal & Regulatory 6 Other Announcement 5 Annual General Meeting 4 Financial Results 3 Results Update 2 Dividend 2 Board Meeting Date 2 Capacity Expansion 1 Business Update 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

3 Jun 2026 21:03 IST BSE

Adverse Business Impact

AstraZeneca Pharma India Adverse Business Impact

AstraZeneca Pharma India Limited surrendered its factory license following its manufacturing site exit. This administrative move marks the final phase of closing its domestic production facility.

Read the filing ↗